01—History
Net Income History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2019–FY2025. Drag across the bars to change the range.
- $26.80B
1 older move runs past ±150% (largest +1076.7%); point at, tap or drag across the bars to read one.
02—Ledger
Net Income, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $26.80B | +90.6% | 10-K | |
| FY2024 | $14.07B | −60.0% | 10-K | |
| FY2023 | $35.15B | +68.4% | 10-K | |
| FY2022 | $20.88B | +41.9% | 10-K | |
| FY2021 | $14.71B | −2.7% | 10-K | |
| FY2019 | $15.12B | −1.2% | 10-K | |
| FY2018 | $15.30B | +1076.7% | 10-K | |
| FY2017 | $1.30B | −91.6% | 10-K | |
| FY2016 | $15.41B | −5.6% | 10-K | |
| FY2014 | $16.32B | +18.0% | 10-K | |
| FY2013 | $13.83B | +27.4% | 10-K | |
| FY2012 | $10.85B | −18.6% | 10-K | |
| FY2011 | $13.33B | +8.7% | 10-K | |
| FY2010 | $12.27B | −5.3% | 10-K | |
| FY2008 | $12.95B | +22.4% | 10-K | |
| FY2007 | $10.58B | — | 10-K |
03—Questions
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is JOHNSON & JOHNSON's current net income?
JOHNSON & JOHNSON (JNJ) annual net income for 2025 was $26.80B, a 90.56% increase from 2024. JOHNSON & JOHNSON net income for the quarter ending June 28, 2026 was $5.53B.
What was JOHNSON & JOHNSON's net income in 2024?
JOHNSON & JOHNSON annual net income for 2024 was $14.07B, a 59.99% decline from 2023.
What was JOHNSON & JOHNSON's net income in 2023?
JOHNSON & JOHNSON annual net income for 2023 was $35.15B, a 68.37% increase from 2022.
What is JOHNSON & JOHNSON's 4-year net income CAGR?
JOHNSON & JOHNSON net income grew at a compound annual growth rate (CAGR) of 16.18% from FY2021 to FY2025, going from $14.71B to $26.80B over 4 years.
- Company
- JOHNSON & JOHNSON
- Ticker
- JNJ
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations